Literature DB >> 11586048

Morning and evening plasma melatonin and dexamethasone suppression test in patients with nonseasonal major depressive disorder from northern Greece (latitude 40-41.5 degrees ).

K N Fountoulakis1, M Karamouzis, A Iacovides, J Nimatoudis, J Diakogiannis, G Kaprinis, A Demitriadou, P Bech.   

Abstract

INTRODUCTION: The present study aimed to search for correlations between melatonin (MT) levels and the dexamethasone suppression test (DST) and clinical variables.
METHODS: Fifty depressed patients aged 21-60 years took part in the study. The Schedules for Clinical Assessment in Neuropsychiatry, version 2.0, and the International Personality Disorders Examination were used for diagnosis. Psychometric assessment included the Hamilton Depression Rating Scale, the Hamilton Anxiety Scale, the General Assessment of Funtioning Scale, the Newcastle scales and the Diagnostic Melancholia Scale. The DST and 9.00 and 23.00 h MT values were assessed. Statistical analysis included Student's t test, Pearson product moment correlation coefficient and forward stepwise multiple linear regression analysis.
RESULTS: Melancholic patients had lower 23.00 h MT values in comparison to the rest of the patients and the atypical and 'undifferentiated' patients.
CONCLUSION: The current study shows that low MT values were closely related to melancholic depression. Distinct quality of mood, psychomotor agitation or retardation and anorexia or weight loss seemed to be responsible for this relationship. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11586048     DOI: 10.1159/000054928

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  9 in total

1.  Dendritic cell nuclear protein-1 regulates melatonin biosynthesis by binding to BMAL1 and inhibiting the transcription of N-acetyltransferase in C6 cells.

Authors:  Dong Chen; Yi-Pei Li; Yan-Xia Yu; Tian Zhou; Chao Liu; Er-Kang Fei; Feng Gao; Chen-Chen Mu; Hai-Gang Ren; Guang-Hui Wang
Journal:  Acta Pharmacol Sin       Date:  2017-12-07       Impact factor: 6.150

2.  Disruption of biological rhythms as a core problem and therapeutic target in mood disorders: the emerging concept of 'rhythm regulators'.

Authors:  Konstantinos N Fountoulakis
Journal:  Ann Gen Psychiatry       Date:  2010-01-13       Impact factor: 3.455

3.  Neuroimmune endocrine effects of antidepressants.

Authors:  Marco Antonioli; Joanna Rybka; Livia A Carvalho
Journal:  Neuropsychiatr Dis Treat       Date:  2012-02-07       Impact factor: 2.570

4.  Is there a dysfunction in the visual system of depressed patients?

Authors:  Konstantinos N Fountoulakis; Fotis Fotiou; Apostolos Iacovides; George Kaprinis
Journal:  Ann Gen Psychiatry       Date:  2005-03-29       Impact factor: 3.455

5.  Melancholic-Like behaviors and circadian neurobiological abnormalities in melatonin MT1 receptor knockout mice.

Authors:  Stefano Comai; Rafael Ochoa-Sanchez; Sergio Dominguez-Lopez; Francis Rodriguez Bambico; Gabriella Gobbi
Journal:  Int J Neuropsychopharmacol       Date:  2015-01-31       Impact factor: 5.176

Review 6.  Circadian Rhythm Disturbances in Mood Disorders: Insights into the Role of the Suprachiasmatic Nucleus.

Authors:  Chelsea A Vadnie; Colleen A McClung
Journal:  Neural Plast       Date:  2017-11-05       Impact factor: 3.599

7.  Depression and coronary heart disease.

Authors:  Karina W Davidson
Journal:  ISRN Cardiol       Date:  2012-11-22

8.  Revisiting the Dexamethasone Suppression Test in unipolar major depression: an exploratory study.

Authors:  Konstantinos N Fountoulakis; Xenia Gonda; Zoltan Rihmer; Costas Fokas; Apostolos Iacovides
Journal:  Ann Gen Psychiatry       Date:  2008-11-13       Impact factor: 3.455

9.  Season of birth, clinical manifestations and Dexamethasone Suppression Test in unipolar major depression.

Authors:  Konstantinos N Fountoulakis; Apostolos Iacovides; Michael Karamouzis; George S Kaprinis; Charalambos Ierodiakonou
Journal:  Ann Gen Psychiatry       Date:  2007-08-03       Impact factor: 3.455

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.